PainReform Ltd (NASDAQ:PRFX) announced results from new studies demonstrating the superior in-vitro release (IVR) rates of PRF-110 compared to topical post-surgical pain management products available ...

Building on PRF’s sustainability philosophy – to look at their prepreg materials from every angle – PRF’s R&D team have ...

Continuous Process Manufacturing: Streamlining production to ensure constant and efficient output, thereby significantly reducing downtime and increasing overall productivity. Single Reactor ...

TEL AVIV, Israel, July 24, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of ...

The average human lifespan has risen steadily, as prosperity and living standards have increased in many parts of the world. Increased lifespan is a cause for celebration. However, longer lifespans ...